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Background and Purpose—Spontaneous vertebral artery dissection (sVADs) mainly cause cerebral ischemia, with or
without associated local symptoms and signs (headache, neck pain, or cervical radiculopathy), or with local symptoms
and signs only.
Methods—We compared the presenting characteristics of consecutive patients with single sVADs and ischemic events and
those with local symptoms and signs only.
Results—Of the 186 patients with first-ever unilateral sVAD, 165 (89%) presented with cerebral ischemia, and 21 (11%)
presented with local symptoms and signs only. Patients with sVAD and ischemia were more often male (63% vs 29%;
P0.002), older (meanSD age, 43.69.9 vs 38.69.0 years; P0.027), and smokers (14% vs 3%; P0.010), but less
often, they had a history of migraine without aura (17% vs 38%; P0.025) than did patients without ischemia. The
multivariate analysis confirmed independent associations between male sex (P0.024), increasing age (0.027), and
smoking (P0.012) and sVADs causing cerebral ischemia.
Conclusions—These results suggest that men, older patients, and smokers with sVADs may be at increased risk for
ischemic events. (Stroke. 2010;41:802-804.)
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The clinical presentation of spontaneous vertebral arterydissection (sVAD) is highly variable.1 Patients with
sVAD may present with local symptoms, ischemia, or both. A
case-control study suggested that hypertension might be
associated with spontaneous cervical artery dissection
(sCAD) causing ischemia.2 In an observational study, we
found that hypercholesterolemia was more frequent in sub-
jects with spontaneous internal carotid artery dissections with
ischemic events than in those without.3
The aim of the present prospective, observational study
was to compare the prevalence of presenting characteristics in
patients with unilateral first-ever sVADs and cerebral ische-
mia with those who experienced merely local symptoms and
signs.
Patients and Methods
We prospectively collected data on consecutive patients with first-
ever sCAD. All patients with single sVADs were included in the
present study. The diagnosis of sVAD was established according to
previously published criteria.1 Patients with multiple sCADs (simul-
taneous occurrence of 1 sCAD) and patients with subarachnoid
hemorrhage were excluded from this study. Clinical and imaging
findings of some patients have been reported previously.1,4,5
The following characteristics were assessed at baseline, as re-
ported previously3: smoking, past smoking, hypertension, migraine,
family history of sCAD, connective-tissue disorders, minor trauma,
and hypercholesterolemia. Cholesterol levels were determined either
within 48 hours after admission or at the 3-month follow-up.
Diabetes mellitus was defined as a history of diabetes mellitus, a
fasting venous plasma glucose concentration on at least 2 separate
occasions of 7.0 mmol/L, or a glucose concentration
11.1 mmol/L 2 hours after oral ingestion of 75 g glucose. Patients
with sVAD were categorized, according to their presenting symp-
toms and signs, into 2 groups: (1) local symptoms or signs only:
headache, neck pain, pulsatile tinnitus, or cervical radiculopathy on
the side of the dissection; and (2) ischemic events (posterior
circulation ischemic stroke (24 hours), transient ischemic attack
(24 hours), or spinal ischemia. Patients with subarachnoid hemor-
rhage were excluded from the study (n6).
Statistical analysis was performed with the SPSS 10.0 program.
For differences in categorical variables, a 2 or Fisher exact test was
used. Continuous variables were compared with the Mann-Whitney
test. The following variables were analyzed: age, family history of
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dissection, connective-tissue disorders, smoking, past smoking, hy-
pertension, diabetes mellitus, hypercholesterolemia, mean plasma
cholesterol level, history of migraine with aura, history of migraine
without aura, current use of oral contraceptives in women 50 years
of age, minor trauma, and interval from symptom onset to diagnosis.
Then, logistic multivariable regression analysis with a forward
stepwise method was performed including all variables with a
probability value 0.2 in the univariate analysis.
Results
Of the 867 consecutive patients with sCAD, 186 (110 men,
59%) were diagnosed with a single sVAD. Among the 186
single-sVAD patients, 165 had an ischemic event (89%), and
21 had local symptoms or signs only (11%).
The presenting ischemic events included stroke in 141
(76.8%) and transient ischemic attack in 24 (12.9%) patients.
The presenting clinical manifestation in the group without
ischemia was isolated pain in 20 patients (10.8%) and
cervical radiculopathy in 1 patient (0.5%). Presenting char-
acteristics for sVADs causing ischemia versus no ischemia
are shown in the Table. On univariate analysis, patients with
sVAD and ischemic events were more often male (63% vs
29%; P0.002), older (meanSD age, 43.69.9 vs
38.69.0 years; P0.027), and more frequently smokers
(43% vs 14%; P0.010), but less often, they had a history of
migraine without aura (17% vs 38%; P0.025) compared
with patients without ischemia. The other presenting charac-
teristics did not differ between the 2 groups (Table). After
multivariable regression analysis, independent associations
between male sex (P0.024), age (P0.027), and smoking
(P0.012) and patients with sVAD causing ischemic events
remained significant.
Discussion
We found that male sex, increasing age, and smoking were
independently associated with sVAD causing ischemia. The
association of male sex with ischemia in this study is in
agreement with recent epidemiological data from several
European countries showing higher age-adjusted incidence
rates for men than women for ischemic stroke. Moreover, a
recent systemic review reported a 33% higher incidence rate
of stroke in men than in women.6 However, in those studies,
ischemic stroke subtypes were not analyzed. A possible cause
of the higher risk of ischemia in men with sVADs might be
the protective effect of estrogens in women. Estrogens may
contribute to better endothelial function and more effective
repair mechanisms in women after sVAD. However, protec-
tive effects of estrogens on the vascular endothelium in
animal studies and experimental studies in postmenopausal
women could not be confirmed by a clinical benefit on the
frequency of vascular events in large randomized, controlled
trials. Hormone replacement therapy is even associated with
an increased risk of stroke.7 Furthermore, oral contraceptives
have been reported to be associated with an increased risk for
ischemic stroke,8 and in the present study, oral contraceptive
use in young women did not differ between sVAD patients
with and without ischemia. It might also be possible that
selection bias is responsible for this sex effect because
women may more readily seek medical advice in case of
isolated local symptoms.
The association of increasing age and sVAD with ischemia
has not been reported so far. One could hypothesize that
increasing inflammation and increasing susceptibility to
thrombosis with increasing age may explain this result.
Increasing age is known to be 1 of the most important risk
factors for ischemic stroke, and the age-specific stroke
incidence rates increase progressively with each decade of
life in both men and women.9
There are several possible explanations for the present
finding that smoking may predispose to cerebral ischemia in
Table. Presenting Characteristics in 186 Patients With Unilateral sVAD Causing Ischemia, or
Local Symptoms and Signs Only
Characteristics
Ischemia
(n165)
Local Symptoms and
Signs Only (n21)
P Value,
Univariate
P Value,
Multivariate
Men 104 (63%) 6 (29%) 0.002 0.024
Mean age (SD), y 43.6 (9.9) 38.6 (10.3) 0.027 0.027
Family history of cervical artery
dissection
1 (0.5%) 0 1.000
Connective-tissue disorder 3 (1.8%) 0 1.000
Smoking 70 (43%) 3 (14%) 0.010 0.012
Past smoking 17 (11%) 0 (0%) 0.226
Hypertension 47 (29%) 3 (14%) 0.199 0.552
Diabetes mellitus 5 (3%) 0 (0%) 1.000
Hypercholesterolemia 90 (62%) 10 (60%) 0.937
Mean plasma cholesterol
(SD), mmol/L
5.5 (1.3) 5.3 (1.2) 0.624
Migraine with aura 11 (7%) 3 (14%) 0.232
Migraine without aura 28 (17%) 8 (38%) 0.025 0.127
Oral contraceptive use in women
50 years of age
12/40 (30%) 3/12 (25%) 0.737
Minor trauma 32 (19%) 2 (10%) 0.281
Mean interval to diagnosis (SD), d 7 (9) 8 (8) 0.549
P indicates difference between subgroups by 2 test, Fisher exact test, or Mann-Whitney test.
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acute sVAD. In smokers, endothelial function is impaired,
and the coagulation cascade is activated. This might enhance
thrombus formation in the dissected artery and increase the
risk of cerebral embolization leading to cerebral ischemia.
Cigarette smoke extracts enhance platelet activation and
increase the susceptibility of platelets to activation by shear
stress.10 Potential mechanisms of this activation include
oxidative stress and increased levels of fibrinogen,
thromboxane, and platelet-derived nitric oxide.11,12 Further-
more, inhibition of substance P–induced tissue plasminogen
activator release has been observed in smokers. Thus, im-
paired endogenous fibrinolysis might predispose smokers
with sVAD to thrombus formation.13 Finally, an association
between smoking and impaired endothelium-dependent vaso-
dilatation has been reported.14 In addition, several inflamma-
tory markers, including leukocyte count, C-reactive protein,
fibrinogen, tumor necrosis factor, and interleukin-6, have
been shown to be elevated in smokers.15
This study has several methodological limitations. This
was a 3-center, university hospital–based study, with a
potential referral bias. Moreover, it is possible that patients
with isolated local symptoms do not seek medical attention.
Another limitation is the small sample size of the sVAD
group without ischemia. However, sVAD is a relatively rare
disease, and our sample constitutes the largest reported series
of patients with single sVAD to date. Nevertheless, our
results have to be confirmed by an independent cohort.
In conclusion, the present results suggest that male sex,
increasing age, and cigarette smoking predispose to ischemic
events in patients with sVAD. This indicates that stroke risk
factors may also play a role in the development of cerebral
ischemia in sVAD.
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